Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan

BACKGROUND: The real-world data for the effectiveness and safety of sofosbuvir/ledipasvir (SOF/LDV) with or without ribavirin (RBV) in patients with hepatitis C virus genotype 1 (HCV-1) infection remain limited in Taiwan. METHODS: A total of 273 chronic HCV-1 patients receiving 8, 12, or 24 weeks of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Liu, Chen-Hua, Liu, Chun-Jen, Su, Tung-Hung, Yang, Hung-Chih, Hong, Chun-Ming, Tseng, Tai-Chung, Chen, Pei-Jer, Chen, Ding-Shinn, Kao, Jia-Horng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6303025/
https://ncbi.nlm.nih.gov/pubmed/30576344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0209299
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia